Meihua International Medical Technologies Co

Meihua International Medical Technologies Co. engages in the manufacture, research & development and sales of class I, II and III disposable medical devices through its operating subsidiaries. The company was founded by Yong Jun Liu and is headquartered in Yangzhou, China.

Meihua International Medical Technologies Co. engages in the manufacture, research & development and sales of class I, II and III disposable medical devices through its operating subsidiaries. The company was founded in 1991 by Yong Jun Liu and is headquartered in Yangzhou, China.

YANGZHOU, China , Nov. 14, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Limited ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today reported its unaudited financial results for the six months ended June 30, 2022. First Half 2022 Unaudited Financial Highlights Total Revenues increased by 13% to approximately $54.8 million for the six months ended June 30, 2022, from approximately $48.4 million in the same period of fiscal year 2021.

Meihua International Medical Technologies Co., Limited Reports Unaudited 2022 First Half Financial Results

YANGZHOU, China , Aug. 1, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today reported its financial results for the fiscal year ended December 31, 2021.

Meihua International Medical Technologies Co., Ltd. Reports 2021 Financial Year Results

Bausch Health Companies Inc

Bausch + Lomb Corp

Medtronic

Tenon Medical Inc

Virax Biolabs Group Ltd

At least one group is bullish about the outlook for the medtech industry: venture capitalists.

Investors May Want to Follow Progress of VC-Backed Medtechs

NEW YORK , July 20, 2022 /PRNewswire/ -- Sadis & Goldberg has been retained by stockholders of Meihua International Medical Technologies Co., Ltd. (NASDAQ:  Ticker "MHUA")  to investigate alleged accounting fraud by MHUA and/or its officers and directors.

Sadis & Goldberg Retained to Investigate Allegations of Accounting Fraud at Meihua International Medical Technologies Co., Ltd. (MHUA)

YANGZHOU, China , May 20, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that on May 18, 2022, it received notice from The Nasdaq Stock Market ("Nasdaq") that, because the Company has not yet filed its annual report on Form 20-F for the year ended December 31, 2021, the Company is out of compliance with the Nasdaq rules for continued listing (specifically, Rule 5250(c)(1)).

Meihua International Medical Technologies Co., Ltd. Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 20-F

YANGZHOU, China, Feb. 18, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced the closing of its initial public offering (the "Offering") of 3,940,000 ordinary shares at a public offering price of $10.00 per ordinary share (the "Ordinary Shares") which includes 340,000 Ordinary Shares issued pursuant to the partial exercise of the underwriters' over-allotment option, for aggregate gross proceeds of $39.4 million before deducting underwriting discounts and commissions and offering expenses.

Meihua International Medical Technologies Co., Ltd. Announces Closing of $39.4 Million Initial Public Offering

The muted market reception isn't too surprising, since the listing has come from a relatively low-tech disposable medical device maker called Meihua International Medical Technologies Co., Ltd.

Investors Give, Then Take Away, In Meihua's New York Trading Debut

Meihua International Medical Technologies Co., Ltd (NASDAQ:MHUA) opened up its shares for public trading for the first time since it filed for IPO in August 2021. The company agreed to initially offer 3.60 million shares to the public at a $10.00 per share.

Meihua International Medical Technologies Co., Ltd Stock Up 4.80% Since IPO

YANGZHOU, China, Feb. 16, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced the pricing of its initial public offering (the "Offering") of 3,600,000 ordinary shares at a public offering price of $10.00 per ordinary share (the "Ordinary Shares"), for total gross proceeds of $36,000,000 before deducting underwriting discounts and commissions and offering expenses.

Meihua International Medical Technologies Co., Ltd. Announces Pricing of $36,000,000 Initial Public Offering

Meihua International Medical Technologies has filed proposed terms for a $50 million U.S. IPO. The firm sells various types of medical devices in China.

News for Meihua International Medical Technologies Co Stock (MHUA)